GGrantIndex
← Leaderboards

Jenny L. Wiley

Virginia Commonwealth University

$18,479,501
Attributed
$18,711,046
Total exposure
13
Grants
13
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.6M · FY200521
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21

Funding mix

By agency

NIH$19,837,339 · 14

By mechanism

R01$15,503,118 · 7
R33$1,847,662 · 1
P01$1,589,383 · 3
R21$412,181 · 1
R13$287,500 · 1
R03$197,495 · 1

Top collaborators

Most similar at Virginia Commonwealth University

Same institution · by research overlap

Others in their field

Top investigators on “Cannabinoids

Research focus

CannabinoidsBrainCannabinoid ReceptorPharmaceutical PreparationsLigandsBehaviorReceptorPharmacologyEndocannabinoidsAcuteTetrahydrocannabinolBaseBehavioralReceptor FunctionInvestigationCannabisDependenceAnimal ModelAreaPhysiologicalSubstance Abuse ProblemPainIn VivoReceptor Binding

Grant awards (65)

Comparative Pharmacology of Cannabinoids in Rodent Models$424,908
R01 · FY2021 · DA · contact PI
Co-Abuse Cannabis and Tobacco$817,694
R33 · FY2020 · DA · contact PI
Minor Cannabinoids and Terpenes: Preclinical Evaluation as Analgesics$470,529
R01 · FY2020 · AT · contact PI
Investigation of Synthetic Cannabinoid Exposures and Pharmacological Consequences$458,135
R01 · FY2020 · DA · contact PI
Comparative Pharmacology of Cannabinoids in Rodent Models$457,972
R01 · FY2020 · DA · contact PI
Minor Cannabinoids and Terpenes: Preclinical Evaluation as Analgesics$210,096
R01 · FY2020 · AT · contact PI
Co-Abuse Cannabis and Tobacco$203,998
R33 · FY2020 · DA · contact PI
Co-Abuse Cannabis and Tobacco$825,970
R33 · FY2019 · DA · contact PI
Minor Cannabinoids and Terpenes: Preclinical Evaluation as Analgesics$487,581
R01 · FY2019 · AT · contact PI
Investigation of Synthetic Cannabinoid Exposures and Pharmacological Consequences$458,132
R01 · FY2019 · DA · contact PI
Comparative Pharmacology of Cannabinoids in Rodent Models$439,309
R01 · FY2019 · DA · contact PI
Comparative Pharmacology of Cannabinoids in Rodent Models$526,837
R01 · FY2018 · DA · contact PI
Investigation of THC Receptors$451,240
R01 · FY2018 · DA · contact PI
Co-Abuse Cannabis and Tobacco$133,338
R21 · FY2018 · DA · contact PI
Investigation of THC Receptors$614,658
R01 · FY2017 · DA · contact PI
Co-Abuse Cannabis and Tobacco$278,843
R21 · FY2017 · DA · contact PI
Investigation of THC Receptors$618,351
R01 · FY2016 · DA · contact PI
Sex Differences in Cannabinoid Dependence and Analgesia$380,522
R01 · FY2016 · DA · contact PI
ICRS Symposium on the Cannabinoids$12,500
R13 · FY2016 · DA · contact PI
Investigation of THC Receptors$624,877
R01 · FY2015 · DA · contact PI
Sex Differences in Cannabinoid Dependence and Analgesia$541,090
R01 · FY2015 · DA · contact PI
Sex Differences in Cannabinoid Dependence and Analgesia (parent grant)$213,618
R01 · FY2015 · DA · contact PI
ICRS Symposium on the Cannabinoids$25,000
R13 · FY2015 · DA · contact PI
Investigation of THC Receptors$644,804
R01 · FY2014 · DA · contact PI
Sex Differences in Cannabinoid Dependence and Analgesia$637,587
R01 · FY2014 · DA · contact PI
Endocannabinoid Discrimination$332,783
R01 · FY2014 · DA · contact PI
Sex Differences in Cannabinoid Dependence and Analgesia$106,855
R01 · FY2014 · DA · contact PI
ICRS Symposium on the Cannabinoids$25,000
R13 · FY2014 · DA · contact PI
Diversity Research Supplement for Sex Differences in Cannabinoid Dependence and Analgesia$17,104
R01 · FY2014 · DA · contact PI
Sex Differences in Cannabinoid Dependence and Analgesia$363,521
R01 · FY2013 · DA · contact PI
Endocannabinoid Discrimination$294,037
R01 · FY2013 · DA · contact PI
ICRS Symposium on the Cannabinoids$25,000
R13 · FY2013 · DA · contact PI
Investigation of THC Receptors$398,928
R01 · FY2012 · DA · contact PI
Sex Differences in Cannabinoid Dependence and Analgesia$374,942
R01 · FY2012 · DA · contact PI
Endocannabinoid Discrimination$303,824
R01 · FY2012 · DA · contact PI
Behavioral Pharmacology of Synthetic Cannabinoids$98,779
R03 · FY2012 · DA · contact PI
ICRS Symposium on the Cannabinoids$25,000
R13 · FY2012 · DA · contact PI
Investigation of THC Receptors$427,839
R01 · FY2011 · DA · contact PI
Endocannabinoid Discrimination$301,420
R01 · FY2011 · DA · contact PI
Behavioral Pharmacology of Synthetic Cannabinoids$98,716
R03 · FY2011 · DA · contact PI
ICRS Symposium on the Cannabinoids$25,000
R13 · FY2011 · DA · contact PI
Investigation of THC Receptors$365,157
R01 · FY2010 · DA · contact PI
Endocannabinoid Discrimination$248,063
R01 · FY2010 · DA · contact PI
ICRS Symposium on the Cannabinoids$30,000
R13 · FY2010 · DA · contact PI
Investigation of THC Receptors$18,907
R01 · FY2010 · DA · contact PI
Endogenous Cannabinoids and Brain Function$1,126,293
P01 · FY2009 · DA · contact PI
Investigation of THC Receptors$380,738
R01 · FY2009 · DA · contact PI
Project 1$326,590
P01 · FY2009 · DA · contact PI
Core$136,500
P01 · FY2009 · DA · contact PI
ICRS Symposium on the Cannabinoids$30,000
R13 · FY2009 · DA · contact PI
Investigation of THC Receptors$378,809
R01 · FY2008 · DA · contact PI
Developmental Pharmacology of Cannabinoids$149,186
R01 · FY2008 · DA · contact PI
Developmental Pharmacology of Cannabinoids$94,734
R01 · FY2008 · DA · contact PI
ICRS Symposium on the Cannabinoids$30,000
R13 · FY2008 · DA · contact PI
Developmental Pharmacology of Cannabinoids$248,898
R01 · FY2007 · DA · contact PI
Developmental Psychopharmacology of Antipsychotics$241,787
R01 · FY2007 · MH · contact PI
ICRS Symposium on the Cannabinoids$30,000
R13 · FY2007 · DA · contact PI
Developmental Pharmacology of Cannabinoids$256,332
R01 · FY2006 · DA · contact PI
Developmental Psychopharmacology of Antipsychotics$249,008
R01 · FY2006 · MH · contact PI
ICRS Symposium on the Cannabinoids$30,000
R13 · FY2006 · DA · contact PI
Developmental Pharmacology of Cannabinoids$262,500
R01 · FY2005 · DA
Developmental Psychopharmacology of Antipsychotics$255,000
R01 · FY2005 · MH
Developmental Pharmacology of Cannabinoids$262,500
R01 · FY2004 · DA
Developmental Psychopharmacology of Antipsychotics$255,000
R01 · FY2004 · MH
Developmental Psychopharmacology of Antipsychotics$255,000
R01 · FY2003 · MH